Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.

Ogunjimi B, Van Damme P, Beutels P.

PLoS One. 2013 Jun 21;8(6):e66485. Print 2013.

2.

The effect of vaccination on the epidemiology of varicella zoster virus.

Edmunds WJ, Brisson M.

J Infect. 2002 May;44(4):211-9. Review.

PMID:
12099726
3.

Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.

Ogunjimi B, Willem L, Beutels P, Hens N.

Elife. 2015 Jul 11;4. doi: 10.7554/eLife.07116.

4.

Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.

Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P.

Am J Epidemiol. 2013 May 15;177(10):1134-42. doi: 10.1093/aje/kws370. Epub 2013 Apr 1.

5.

Universal varicella vaccination: efficacy trends and effect on herpes zoster.

Goldman GS.

Int J Toxicol. 2005 Jul-Aug;24(4):205-13.

PMID:
16126614
6.

VZV T cell-mediated immunity.

Weinberg A, Levin MJ.

Curr Top Microbiol Immunol. 2010;342:341-57. doi: 10.1007/82_2010_31. Review.

PMID:
20473790
7.

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. Review.

8.

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Brisson M, Gay NJ, Edmunds WJ, Andrews NJ.

Vaccine. 2002 Jun 7;20(19-20):2500-7.

PMID:
12057605
10.

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.

van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ.

Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23.

PMID:
22119592
11.

Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.

Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ.

BMC Infect Dis. 2012 May 10;12:110. doi: 10.1186/1471-2334-12-110.

12.

Varicella-zoster virus.

Arvin AM.

Clin Microbiol Rev. 1996 Jul;9(3):361-81. Review.

13.

Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.

Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF.

J Infect Dis. 2005 Jun 15;191(12):2002-7. Epub 2005 May 12.

14.

CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.

Haberthur K, Engelmann F, Park B, Barron A, Legasse A, Dewane J, Fischer M, Kerns A, Brown M, Messaoudi I.

PLoS Pathog. 2011 Nov;7(11):e1002367. doi: 10.1371/journal.ppat.1002367. Epub 2011 Nov 10.

15.

Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.

Breuer J, Whitley R.

Herpes. 2007 Sep;14 Suppl 2:25-9. Erratum in: Herpes. 2007 Dec;14(3):74.

PMID:
17939892
16.

Varicella-zoster virus: overview and clinical manifestations.

Arvin AM.

Semin Dermatol. 1996 Jun;15(2 Suppl 1):4-7. Review.

PMID:
8840410
17.
18.

The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.

Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16.

PMID:
19536039
19.

Does varicella-zoster virus infection of the peripheral ganglia cause Chronic Fatigue Syndrome?

Shapiro JS.

Med Hypotheses. 2009 Nov;73(5):728-34. doi: 10.1016/j.mehy.2009.04.043. Epub 2009 Jun 10.

PMID:
19520522
20.

Immunology of Varicella Immunization in the elderly.

Raeder CK, Hayney MS.

Ann Pharmacother. 2000 Feb;34(2):228-34. Review.

PMID:
10676831
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk